Page values for "Donepezil"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Donepezil |
| brand | String | Aricept (oral), Adlarity (transdermal patch) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Anti-dementia medicines|Anti-dementia medicine]] • [[:Category:Acetylcholinesterase inhibitors|Acetylcholinesterase inhibitor]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"' |
| starting_dose | String | 5 mg PO once daily at bedtime; titrate to 10 mg/day after 4-6 weeks. Severe Alzheimer disease: may escalate to 23 mg/day. Adlarity patch: 5 or 10 mg/day applied weekly |
| preparations | String | Oral tablets 5, 10, 23 mg; ODT 5, 10 mg; Adlarity transdermal patch 5, 10 mg/day (weekly application) |
| fda_max | String | 23 mg/day |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • transdermal |
| onset | String | Cognitive effect emerges gradually over weeks to months; ceiling effect at the therapeutic dose |
| duration | String | 24 hours (once-daily dosing) |
| halflife | String | ~70 hours (long, supports once-daily dosing without peak-trough variation)'"`UNIQ--ref-0000001B-QINU`"' |
| bioavailability | String | ~100% (oral)'"`UNIQ--ref-0000001C-QINU`"' |
| pregnancy | String | Limited human data; rarely indicated in pregnancy given the patient population.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |